Purpose Planning for radiation oncology requires reliable estimates of both demand for radiotherapy and availability of technological resources. This study compares radiotherapy resources in the 17 regions of the decentralised Spanish National Health System (SNHS). Materials and methods The Sociedad Española de Oncología Radioterápica (SEOR) performed a cross-sectional survey of all Spanish radiation oncology services (ROS) in 2015. We collected data on SNHS radiotherapy units, recording the year of installation, specific features of linear accelerators (LINACs) and other treatment units, and radiotherapeutic techniques implemented by region. Any machine over 10 years old or lacking a multileaf collimator or portal imaging system was considered obsolete. We performed a k-means clustering analysis using the Hartigan-Wong method to test associations between the gross domestic regional product (GDRP), the number of LINACs per million population and the percentage of LINACs over 10 years old. Results The SNHS controls 72 (61%) of the 118 Spanish ROS and has 180 LINACs, or 72.5% of the total public and private resources. The mean rate of LINACs per million population is 3.9 for public ROS, and 42% (n = 75) of the public accelerators were obsolete in 2015: 61 due to age and 14 due to technological capability. There was considerable regional variation in terms of the number and 
Introduction
Planning for radiation oncology requires a reliable estimate of the demand for radiotherapy in a specific population. In Europe, the first attempt [1] to estimate infrastructure and planning needs for radiation oncology services (ROS) across the EU was based on a 2003 study from Australia [2] , which concluded that external beam radiotherapy was indicated for about 52.3% of tumours. More recently, a study based on the work of Barton [3] and analyses from Borràs in the ESTRO-HERO (European Society for Radiation Oncology-Health Economics in Radiation Oncology) project [4, 5] reported that about 50.5% of new cancer cases in Spain require radiotherapy at least once [6] . Additional demand comes from re-treatments, re-radiation, non-melanoma skin cancer and benign pathologies. The same study estimated that 25-30% of those with an indication for radiotherapy do not receive it due to geographical and transportation-related factors; associated comorbidities; patient preferences; inadequate knowledge of radiotherapy among other specialists; and lack of human and physical resources, which entail wait lists and delays [4] [5] [6] .
In Spain, the direct costs of cancer stood at EUR 4.82 billion in 2011-4.9% of the total health-care expenditure. Radiotherapy cost EUR 248 million, or 5.1% of the total direct costs of cancer and 0.25% of the total health-care expenditure [7] . Because substantial capital investments are necessary to purchase radiation oncology equipment, this specialty is perceived as relatively expensive, prompting intense debate about its necessity. However, the equipment has a long useful life, and the initial layout is balanced by modest costs per patient and service.
Having assessed the demand for radiotherapy in Spain [6] , the next step is to analyse the availability of technical resources, identifying deficits and planning for the system's needs. The Spanish health system is based on the National Health Service (NHS) model, with decentralised administration among 17 regional authorities (plus Ceuta and Melilla); these independently administer a common portfolio of health services guaranteed to all citizens, independently of their place of residence. Given the differences between other European countries and Spain in demographics, cancer incidence, and available radiotherapy equipment, together with the pronounced decentralisation of health services administration, comparing the available resources for external beam radiotherapy among the regions-and the factors explaining any differences-is of great interest.
This study aims to describe the current state of radiotherapy in the Spanish National Health System (SNHS) and in its 17 regions to identify system needs and propose achievable targets.
Materials and methods
The Infrastructure Commission of the Sociedad Española de Oncologia Radioterapica (SEOR) developed a detailed questionnaire on available radiotherapy resources [linear accelerators (LINACs) and other equipment, personnel and hospital resources] and sent it to all chiefs of both public and private ROS in Spain during the fourth quarter of 2015.
This analysis focuses only on SNHS resources. The questionnaire contained separate items for treatment units other than LINACs, such as cobalt-60 units, surface therapy, portable accelerators, tomotherapy, Gamma Knife and CyberKnife. SEOR established requirements for minimal acceptability as a multileaf accelerator with an MV portal imaging system, while the standard was a multileaf accelerator with cone-beam computed tomography (CT). We considered any machine over 10 years old or lacking a multileaf collimator or portal imaging system to be obsolete.
We recorded the year of installation and specific features for each treatment unit.
To explore associations with resource availability across regions, we performed a k-means clustering analysis using the Hartigan-Wong method, which enables representation of multidimensional data on two axes and definition of the centroid cluster (vector with mean values of each variable).
Variables were the gross domestic regional product (GDRP) [8] , the number of LINACs per million population and the percentage of LINACs over 10 years old. We used population data from January 2015 for each region from the Spanish Statistical Office (Table 1) ; data from Andalusia includes the population from the semi-autonomous cities of Ceuta and Melilla.
We used SPSS statistical software (version 21) for all analyses.
Results
We achieved a 100% response rate to our survey. Our results show that the SNHS controls 72 (61%) of the 118 Spanish ROS and has 180 LINACs, or 72.5% of the total public and private resources. The number of inhabitants per ROS ranged from 317,053 in La Rioja to 1,104,479 in the Balearic Islands (Table 1 ). The evolution of ROS resources over the past 30 years (1986-2015) is summarised in Table 2 .
The mean rate of LINACs per million population is 3.9 for public ROS; only seven regions surpass this average, and none meet the recommendation of seven LINACs per million population (Fig. 1a) . Mean daily operating time was 12.32 h, with all regions operating longer than the typical 8-h workday (Fig. 1b) .
Of the 180 LINACs available in public centres, 61 (34%) were older than 10 years. The regions with the oldest machines were Galicia, Cantabria and Castilla La Mancha, while none of the units used in the Balearic Islands, La Rioja and Navarra were deemed obsolete on this criterion (Table 1) . Of the 119 machines installed within the previous 10 years, 74 (41%) were 6-10 years old, with notable heterogeneity among the regions (Table 1) .
Services had one to five accelerators each, with most (76%) having one to two. Just three centres (1.7%) in Andalusia, the Canary Islands and Catalonia, had five. Regarding the associated technology, 88% (n = 159) had a multileaf collimator, 25% (n = 45) had a micro-multileaf collimator, and 43% (n = 77) had a KV or MV cone-beam CT (supplemental table online).
Considering both age-and technology-related criteria for obsolescence, 42% (n = 75) of the public accelerators were obsolete in 2015, and 83% will be in 2020. Fourteen (12%) LINACs were technologically obsolete, while 105 (88%) of the accelerators installed within the previous 10 years were minimally acceptable, and 59.7% (n = 71) were standard.
The results for the 'other units' category are as follows.
• Surface therapy 12 machines installed from 1975 to 2013-4 in Catalonia alone. With regard to the radiotherapeutic techniques implemented in SNHS centres, 81.9% (n = 59 centres) offer intensity-modulated radiation therapy (IMRT) and 79.1% (n = 57) report using some kind of image-guided radiotherapy (IGRT). Volumetric IMRT is performed in 36.1% (n = 26). Other techniques used include: radiosurgery (34.7%, n = 25), brain fractionated stereotactic radiotherapy (43%, n = 31), craniospinal radiation (72.2%, n = 52), stereotactic body radiotherapy (44.4%, n = 32), total body irradiation (33.3%, n = 24), total skin electron irradiation (6.9%, n = 5), intraoperative radiotherapy (9.7%, n = 7) and paediatric radiotherapy (44.4%, n = 32). The distribution of centres offering these techniques is given in Table 3 .
Other data collected (presented in online supplement) include details for each region regarding LINACs (machine age, technology) and ROS (number of machines per centre, types of IMRT offered), as well as an overall description of the external beam radiation techniques offered in public centres.
The cluster analysis enables graphic representation of the three included variables on the two axes that explain 83.2% of the total variability (Fig. 2) . Spanish regions can be classified into four clusters (Table 4) . Cluster 1 represents regions with the highest GDRP, highest rates of accelerators per million population and lowest percentage of obsolete units. Cluster 2 regions have a lower-but still substantial-GDRP and a lower rate of LINACs per million population than the (lower GDRP) regions in cluster 3, although more resources in cluster 3 are obsolete. Finally, cluster 4 regions have the lowest GDRP, lowest rate of LINACs per million population and the highest percentage of obsolete machines in operation.
Discussion
We performed this study to identify gaps and plan for future needs within the comprehensive range of SEOR activities implemented over the past 30 years. With full participation from all ROS, we present comparative data on radiotherapy resources for all Spanish regions. These show considerable variability, consistent with the variability in resources observed between European countries during the ESTRO-HERO project [9, 10] . This pattern suggests that internal analyses within national borders are just as important as inter-country comparisons.
In Spain, the rise in available resources over the past several decades has been notable. The first white paper with data on oncology services, published in 1986, reported just 50 ROS and 75 megavoltage units [11] . Escó and colleagues [12] also described a situation far from ideal using data from 1999, calling for 44 additional LINACs and the substitution of obsolete cobalt-60 units. This study was the first to record differences between regions; the most disadvantaged were Aragon, Castilla La Mancha and Murcia, which at the time were still dependent on the central government (decentralisation was not complete until 2002). Before Palacios et al. performed the next national analysis using data from 2004 [13] , the results of the ESTRO-QUARTS study were published in the first attempt to estimate the infrastructure and human resources available for radiotherapy across Europe [1, 14] . Investigators based their recommendations on objective estimates: 1 LINAC/400-450 treatments/year and 1.6-1.9 accelerators/ 1000 treatments/year. The European average was 5.9 LINACs/million, with stark differences between countries.
Spain did not participate in ESTRO-QUARTS, although a contemporary analysis showed significant growth in infrastructure [13] . The mean number of units per million 27%, radiosurgery; and 10%, stereotactic body radiotherapy. The last SEOR white paper [15] estimated the deficit in accelerators at 40-60 in 2008, but there were clear improvements over previous reports and these have since continued. The SNHS controlled 57% of the operative ROS in 2008, compared to 61% in our study.
The ESTRO-HERO project has provided a snapshot of European radiotherapy. While the results reflect progress in meeting previous recommendations [1], this study and other international analyses [16] show marked betweencountry heterogeneity [4, 5] with limited access to radiotherapy and targeted treatments in some countries.
In the ESTRO-HERO analysis, Spain (with data from 2011 comprising 112 public and private ROS) has an intermediate rank, with 5.6 LINACs/million population and 2.3 LINACs/ROS, for a total of 220 accelerators (\50% equipped with IMRT) and five remaining cobalt-60 units. Similarly to the QUARTS project [1] and other more recent analyses [4, 5] , HERO results showed wide differences between European countries. Our study confirms that within Spain, large variations in available techniques and resources also exist.
Despite investments in the past several years, the situation in Spain is of concern, particularly given the ageing demography that puts Spain on track to become the European country with the oldest population [17] , with Total  25  31  52  32  24  5  7  32 FSRT fractionated stereotactic radiotherapy, IOR intraoperative radiotherapy, SBRT stereotactic body radiotherapy, TBI total body irradiation, TSEI total skin electron irradiation Clin Transl Oncol (2018) 20:402-410 407 implications for rising cancer incidence [18] . Today, even counting LINACs from the private sector backed by public provider agreements, there is an evident gap between evidence-based therapeutic demand and available accelerators [19] . The introduction of techniques like hypofractionation in breast cancer will also have a long-term impact on the total demand, although for now uptake is slow and uneven [20] . More alarming, 42% of the operational stock in 2015 was obsolete. Without new investments, this figure will rise to 83% by 2020 and could reach 100% in six regions. In practical terms, there are only two options for increasing treatment capacity in ROS: acquire more machines or increase their scheduled use. Extending operating hours often entails problems related to the lack of secondary services or auxiliary staff. Moreover, Spanish ROS already operate for around 12 h per day, making it difficult to extend hours longer while still respecting staff and patients' family commitments. Adding another LINAC to the ROS has the benefit of averting interruptions by facilitating patients' mobility and relocation if another unit breaks down, especially in the case of twin accelerators. Thus, extending operating hours is not clearly associated with cost savings compared to purchasing new accelerators.
The increase in available accelerators has been accompanied by an increase in ROS following the devolution of health-care administration that began in the 1990s. Seventy-six per cent of ROS have one to two accelerators, reflecting a notable fragmentation and a near absence of subspecialisation (with some exceptions, for example reflected in the high number of centres offering paediatric radiotherapy). In the Netherlands, the number of ROS did One measure that has helped avoid fragmentation in service provision in this country has been the implementation of satellite services affiliated with a large centre. This move has allowed an adequate provision of accelerators in sparsely population area without compromising the quality of the service. In Spain, a satellite unit in Tortosa (Tarragona) depends on the ROS in the provincial capital of Reus, enabling care of comparable quality for a sparse and extended population [22] , similar to another experience in rural Australia [23] . Given the low-density population in many regions, additional satellite centres can contribute to ensuring equitable and timely access to high-quality radiotherapy for anyone in Spain.
The cluster analysis suggests that the availability of therapeutic resources does not depend on the economic resources of regions, but rather on policy. Although the correlation observed between high GDRP, high rate of LINACs/million population and lower percentage of obsolete machines suggests that the availability of economic resources is decisive for ensuring adequate equipment, the cluster analysis reveals that this is not always true. This situation reflects a decentralised model of decision-making, resulting in notable variability with regard to radiotherapy resources.
One limitation of our study, similar to previous analyses [9, 10] , is that while our data show accelerators' capacity to perform complex techniques, we cannot determine whether the equipment is being used to full capacity.
Ultimately, although we have observed improved availability of LINACs, our results show great heterogeneity between regions that have access to modern radiotherapy units. Some regions show deficits in both the number and the technological capacity of their machines. At the same time, the validity of traditional indicators like machine age and technological capacity is waning. The advent of high-precision techniques and daily image guidance entails a greater use of time and resources, limiting the number of treatments per machine, while the generalised use of moderate hypofractionated treatments for the pathologies most frequently treated with radiotherapy shortens treatment course and modifies the capacity of the units. Thus, in the future we will also need to monitor incidence data and treatment activity.
Today, investments should be directed towards replacing units that are obsolete due to age or technology (42% in 2015 and 83% in 2020), increasing the availability of and access to advanced techniques that characterise modern radiotherapy. Regular analysis of both public and private sectors in each Spanish region is the only strategy for monitoring progress in radiotherapy capacity. When calculating future needs, the role of brachytherapy should not be discounted either. Reducing fragmentation in ROS through the pooling of resources and the development of satellite units linked to high-volume services may also be a useful strategy for our country.
